caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679538516

Robert GleserM.D.

PRACTICERICHARD J FLANIGAN MDSee all providers at this practice →
Internal MedicineDenver, COI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,457
Unique beneficiaries
—
Total services
2,206
Distinct HCPCS
21
Medicare payment
$139K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,144 Internal Medicine providers in CO — top quintile (cohort median 528).
REFERRAL NETWORK

Where Robert Gleser's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NPI 13967811343785
Cher, Llc
Independent Diagnostic Testing Facility (IDTF) · Englewood, CO
3567
UNIVERSITY OF COLORADO HOSPITAL AUTHORITY3379
HCA HEALTHONE LLC2753
HCA HEALTHONE LLC2749
Hani Saeed
Podiatry · Denver, CO
2461
NATIONAL JEWISH HEALTH1945
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
6,769
Beneficiaries
—
Total drug cost
$565K
Distinct drugs
113
Brand share
17.7%
Top prescribed drugs
Atorvastatin Calcium500 claims
Levothyroxine Sodium336 claims
Losartan Potassium317 claims
Rosuvastatin Calcium301 claims
Amlodipine Besylate256 claims
QUALITY · MIPS · 2024
Final MIPS score
81.0
Quality
80.9
Cost
75.9
Improvement activities
40.0
Promoting interop.
76.0
Payment adjustment
0.25%
Subgroup
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.